Jeff E. Knight - Net Worth and Insider Trading

Jeff E. Knight Net Worth

The estimated net worth of Jeff E. Knight is at least $9 Million dollars as of 2026-09-01. Jeff E. Knight is the Chief Dev. & Operating Officer of Crinetics Pharmaceuticals Inc and owns about 105,289 shares of Crinetics Pharmaceuticals Inc (CRNX) stock worth over $9 Million. Details can be seen in Jeff E. Knight's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeff E. Knight has not made any transactions after 2026-04-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Jeff E. Knight

To

Jeff E. Knight Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeff E. Knight owns 2 companies in total, including Crinetics Pharmaceuticals Inc (CRNX) , and ALX Oncology Holdings Inc (ALXO) .

Click here to see the complete history of Jeff E. Knight’s form 4 insider trades.

Insider Ownership Summary of Jeff E. Knight

Ticker Company Transaction Date Type of Owner
CRNX Crinetics Pharmaceuticals Inc 2026-04-08 Chief Operating Officer
ALXO ALX Oncology Holdings Inc 2026-04-13 Chief Dev & Operating Officer

Jeff E. Knight Latest Holdings Summary

Jeff E. Knight currently owns a total of 1 stock. Jeff E. Knight owns 105,289 shares of Crinetics Pharmaceuticals Inc (CRNX) as of April 8, 2026, with a value of $9 Million.

Latest Holdings of Jeff E. Knight

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRNX Crinetics Pharmaceuticals Inc 2026-04-08 105,289 84.95 8,944,301

Holding Weightings of Jeff E. Knight


Jeff E. Knight Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeff E. Knight has made a total of 8 transactions in Crinetics Pharmaceuticals Inc (CRNX) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Crinetics Pharmaceuticals Inc is the sale of 85,163 shares on April 8, 2026, which brought Jeff E. Knight around $3 Million.

Insider Trading History of Jeff E. Knight

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeff E. Knight Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Jeff E. Knight owns.
View CRNX Analysis

Jeff E. Knight Ownership Network

Ownership Network List of Jeff E. Knight

No Data

Ownership Network Relation of Jeff E. Knight

Insider Network Chart


Jeff E. Knight Owned Company Details

What does Crinetics Pharmaceuticals Inc do?

Who are the key executives at Crinetics Pharmaceuticals Inc?

Jeff E. Knight is the Chief Operating Officer of Crinetics Pharmaceuticals Inc. Other key executives at Crinetics Pharmaceuticals Inc include director & See Remarks Richard Scott Struthers , Chief Scientific Officer Stephen F. Betz , and Chief Financial Officer Tobin Schilke .

Crinetics Pharmaceuticals Inc (CRNX) Insider Trades Summary

Over the past 18 months, Jeff E. Knight made 3 insider transaction in Crinetics Pharmaceuticals Inc (CRNX) with a net sale of 102,236. Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 59,007 shares made by Dana Pizzuti , a net sale of 113,865 shares made by Stephen F. Betz , and a net sale of 43,319 shares made by Richard Scott Struthers .

In summary, during the past 3 months, insiders sold 9,900 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 9,900 shares. During the past 18 months, 361,540 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 361,540 shares.

Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Crinetics Pharmaceuticals Inc Insider Transactions

No Available Data

Jeff E. Knight Mailing Address

Above is the net worth, insider trading, and ownership report for Jeff E. Knight. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jeff E. Knight's mailing address is: San Diego Ca 92121.